Related Experiment Video
Updated: Oct 25, 2025

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
A Novel miRNA-mRNA Axis Involves in Regulating Transcriptional Disorders in Pancreatic Adenocarcinoma
Xin Shang1, Lan-Er Shi1, Dina Taule1
1The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, People's Republic of China.
Background:
Currently, there is still a lack of understanding about the mechanism and therapeutic targets of pancreatic adenocarcinoma (PAAD). The potential of miRNA-mRNA networks for the identification of regulatory mechanisms involved in PAAD development remains unexplored.
Methods:
We compared differentially expressed miRNAs (DEMIs) and differentially expressed genes (DEGs) in PAAD and normal tissues from the Gene Expression Omnibus (GEO) database. Transcription factors (TFs) were obtained from FunRich. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses of DEGs and DEMIs were implemented using Database for Annotation, Visualization and Integrated Discovery (DAVID). Then, key miRNAs and targeted mRNAs were identified by assessment of their expression and prognosis in UALCAN and Kaplan-Meier plotters. In the last step, the candidate miRNA-mRNA selected was confirmed by real-time quantitative polymerase chain reaction (qRT-PCR).
Results:
We distinguished 62 significant DEMIs, 1314 upregulated DEGs, and 1110 downregulated DEGs. The top 10 TFs were identified. In total, there were 160 hub genes obtained by intersecting the set of 2224 predicted targets with the set of significant DEGs. And we selected 8 key miRNAs. Furthermore, low expression of miR-455-3p in PAAD tissue was closely connected with poor prognosis, and only 5 target mRNAs were predicted to be increased in PAAD tissue with poor prognosis. Therefore, a novel miRNA-hub gene regulatory network in PAAD was constructed. Finally, in vitro experiments indicated that miR-455-3p expression was decreased in PAAD sample. HOXC4, DLG4, DYNLL1 and FBXO45 were validated by qRT-PCR as highly probable targets of miR-455-3p.
Conclusion:
A novel miRNA-mRNA axis has been discovered that may be involved in the regulation of transcriptional disorders and affected the survival of PAAD patients, which would provide a novel strategy for the treatment of PAAD.
Insights
Researchers identified a novel microRNA (miRNA)-messenger RNA (mRNA) network in pancreatic adenocarcinoma (PAAD). This discovery offers a potential new strategy for treating PAAD by targeting transcriptional dysregulation and patient survival.
Area of Science:
- Oncology
- Molecular Biology
- Bioinformatics
Background:
- Pancreatic adenocarcinoma (PAAD) mechanisms and therapeutic targets remain poorly understood.
- The role of microRNA (miRNA)-messenger RNA (mRNA) networks in PAAD pathogenesis is largely unexplored.
Purpose of the Study:
- To investigate the potential of miRNA-mRNA networks in identifying regulatory mechanisms and therapeutic targets for PAAD.
- To construct a novel miRNA-hub gene regulatory network for PAAD.
Main Methods:
- Differential expression analysis of miRNAs and genes in PAAD tissues using GEO data.
- Identification of transcription factors, hub genes, and key miRNAs.
- Pathway enrichment analysis (GO, KEGG) and survival analysis (UALCAN, Kaplan-Meier).
- Validation of candidate miRNA-mRNA interactions using qRT-PCR.
Main Results:
- Identified 62 differentially expressed miRNAs (DEMIs) and 2424 differentially expressed genes (DEGs).
- Constructed a novel miRNA-hub gene regulatory network, highlighting 8 key miRNAs.
- Found decreased miR-455-3p expression correlated with poor prognosis in PAAD.
- Validated HOXC4, DLG4, DYNLL1, and FBXO45 as probable targets of miR-455-3p.
Conclusions:
- A novel miRNA-mRNA axis (miR-455-3p and its targets) is implicated in PAAD transcriptional dysregulation and survival.
- This finding provides a potential novel therapeutic strategy for PAAD treatment.
Related Concept Videos
MicroRNAs
MicroRNAs
Master Transcription Regulators
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Regulation of Expression at Multiple Steps

